These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Levels of antithrombin III, alpha 2-macroglobulin, and alpha 1-antitrypsin in acute ischemic heart disease. Losito R; Gattiker H; Bilodeau G; Verville N; Longpré B J Lab Clin Med; 1981 Feb; 97(2):241-50. PubMed ID: 6161197 [TBL] [Abstract][Full Text] [Related]
3. [Prognostic significance of serum alpha 1-antitrypsin levels in myocardial infarction]. Solod NN; Iunusov MA Sov Med; 1989; (4):23-6. PubMed ID: 2788308 [TBL] [Abstract][Full Text] [Related]
4. Serum alpha 1-antitrypsin activity in ischaemic heart disease. Vasantha VC; Somayajulu GL; Pai HS J Indian Med Assoc; 1985 Sep; 83(9):297-9. PubMed ID: 3878856 [No Abstract] [Full Text] [Related]
5. Relationship between serum sialic acids, sialic acid-rich inflammation-sensitive proteins and cell damage in patients with acute myocardial infarction. Süer Gökmen S; Kazezoğlu C; Sunar B; Ozçelik F; Güngör O; Yorulmaz F; Gülen S Clin Chem Lab Med; 2006; 44(2):199-206. PubMed ID: 16475908 [TBL] [Abstract][Full Text] [Related]
6. [Kinin-modifying therapy of patients with myocardial infarction]. Miagkov II; Trotsiuk VR; Iasnitskaia MIa Kardiologiia; 1993; 33(1):41-3. PubMed ID: 8035544 [TBL] [Abstract][Full Text] [Related]
7. Changes in protease inhibitors after acute myocardial infarction. Rennie JA; Crawford GP; Ogston D J Clin Pathol; 1976 Jul; 29(7):639-41. PubMed ID: 61974 [TBL] [Abstract][Full Text] [Related]
8. Serum alpha-1-antitrypsin in ischemia and rheumatic heart diseases. Somayajulu GL; Reddy PP Indian J Pathol Microbiol; 1996 Oct; 39(4):271-5. PubMed ID: 9009477 [TBL] [Abstract][Full Text] [Related]
9. Serum Aldosterone as Predictor of Progression of Coronary Heart Disease in Patients Without Signs of Heart Failure After Acute Myocardial Infarction. Resic N; Durak-Nalbantic A; Dzubur A; Begic A; Begic E Med Arch; 2018 Dec; 72(6):406-409. PubMed ID: 30814770 [TBL] [Abstract][Full Text] [Related]
10. Activated protein C levels and outcome in patients with cardiogenic shock complicating acute myocardial infarction. Fellner B; Rohla M; Jarai R; Smetana P; Freynhofer MK; Egger F; Zorn G; Weiss TW; Huber K; Geppert A Eur Heart J Acute Cardiovasc Care; 2017 Jun; 6(4):348-358. PubMed ID: 26936869 [TBL] [Abstract][Full Text] [Related]
11. Effects of Prolastin C (Plasma-Derived Alpha-1 Antitrypsin) on the acute inflammatory response in patients with ST-segment elevation myocardial infarction (from the VCU-alpha 1-RT pilot study). Abbate A; Van Tassell BW; Christopher S; Abouzaki NA; Sonnino C; Oddi C; Carbone S; Melchior RD; Gambill ML; Roberts CS; Kontos MC; Peberdy MA; Toldo S; Vetrovec GW; Biondi-Zoccai G; Dinarello CA Am J Cardiol; 2015 Jan; 115(1):8-12. PubMed ID: 25456867 [TBL] [Abstract][Full Text] [Related]
12. Activation of the contact system in patients with a first acute myocardial infarction. Konings J; Govers-Riemslag JW; Spronk HM; Waltenberger JL; ten Cate H Thromb Res; 2013 Jul; 132(1):138-42. PubMed ID: 23746628 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of biohumoral markers of necrosis and inflammation in patients with right ventricular myocardial infarction. Orozović V; Rafajlovski S; Gligić B; Miailović Z; Obradović S; Ratković N; Djenić N; Baskot B Prilozi; 2007 Jul; 28(1):23-38. PubMed ID: 17921916 [TBL] [Abstract][Full Text] [Related]
14. Blood lactate is a predictor of short-term mortality in patients with myocardial infarction complicated by heart failure but without cardiogenic shock. Gjesdal G; Braun OÖ; Smith JG; Scherstén F; Tydén P BMC Cardiovasc Disord; 2018 Jan; 18(1):8. PubMed ID: 29347907 [TBL] [Abstract][Full Text] [Related]
15. Acute hyperglycaemia and inflammation in patients with ST segment elevation myocardial infarction. Terlecki M; Bednarek A; Kawecka-Jaszcz K; Czarnecka D; Bryniarski L Kardiol Pol; 2013; 71(3):260-7. PubMed ID: 23575781 [TBL] [Abstract][Full Text] [Related]
16. Cardiogenic shock after acute myocardial infarction. Incidence and mortality from a community-wide perspective, 1975 to 1988. Goldberg RJ; Gore JM; Alpert JS; Osganian V; de Groot J; Bade J; Chen Z; Frid D; Dalen JE N Engl J Med; 1991 Oct; 325(16):1117-22. PubMed ID: 1891019 [TBL] [Abstract][Full Text] [Related]
17. Plasma concentrations of interleukin-6, organ failure, vasopressor support, and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarction. Geppert A; Dorninger A; Delle-Karth G; Zorn G; Heinz G; Huber K Crit Care Med; 2006 Aug; 34(8):2035-42. PubMed ID: 16775569 [TBL] [Abstract][Full Text] [Related]